Market Cap 113.00M
Revenue (ttm) 0.00
Net Income (ttm) -27.52M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 83,500
Avg Vol 283,446
Day's Range N/A - N/A
Shares Out 74.34M
Stochastic %K 10%
Beta 0.91
Analysts Strong Sell
Price Target $8.00

Company Profile

Inhibikase Therapeutics, Inc. operates as a clinical-stage pharmaceutical company that develops therapeutics for Parkinson's disease and related disorders. Its lead product candidate is IkT-148009, a non-receptor Abelson tyrosine kinase inhibitor, which is in Phase 2a clinical trials to the treatment of Parkinson's disease and gastrointestinal tract. The company is also developing IkT-001Pro, a prodrug of the anticancer agent imatinib mesylate to treat stable phase chronic myelogenous leukemia....

Industry: Biotechnology
Sector: Healthcare
Phone: (678) 392-3419
Address:
3350 Riverwood Parkway SE, Suite 1900, Atlanta, United States
BillyTheKid62
BillyTheKid62 Aug. 1 at 5:40 PM
$IKT This stock makes my hemmroids bleed faster !
0 · Reply
buffalochips62
buffalochips62 Jul. 31 at 3:10 PM
$IKT seems this is just gonna keep slowly bleeding back to 1. Ugh.
2 · Reply
MB11111
MB11111 Jul. 24 at 2:38 PM
$IKT Ikt is hiring. Clinical trial jobs… https://www.inhibikase.com/careers Careers :: Inhibikase Therapeutics, Inc. (IKT)
1 · Reply
buffalochips62
buffalochips62 Jul. 24 at 1:51 PM
$IKT is the feed to this ticker broken or is it just me? I don’t see any updates in 12 days.?
0 · Reply
Mjf04288
Mjf04288 Jul. 11 at 3:45 PM
$IKT Volume has dried up the past 2 days. Company needs to provide some updates
1 · Reply
buffalochips62
buffalochips62 Jul. 10 at 6:16 PM
$IKT is this dead money for a while or are catalysts coming up in the next couple quarters? Thanks
2 · Reply
Finanz
Finanz Jul. 5 at 8:03 PM
$IKT Time for a short squeeze?
0 · Reply
TJC1791
TJC1791 Jun. 30 at 10:20 PM
$IKT https://www.ainvest.com/news/inhibikase-therapeutics-russell-2500-inclusion-strategic-pivot-small-cap-biotech-investors-parkinson-pipeline-shifts-2507/
1 · Reply
TJC1791
TJC1791 Jun. 28 at 4:31 PM
$IKT @PharmToBank how you feeling about this recent imatinib trial that seems to be well tolerated? Any concerns on the viability of IKT pro?
1 · Reply
Mjf04288
Mjf04288 Jun. 28 at 2:05 AM
$IKT What is going on? After hours volume 7.06 million
1 · Reply
Latest News on IKT
Inhibikase Announces Expansion of Senior Leadership Team

Feb 24, 2025, 8:00 AM EST - 5 months ago

Inhibikase Announces Expansion of Senior Leadership Team


Inhibikase Therapeutics Announces a 1-for-6 Reverse Stock Split

Jun 29, 2023, 9:29 AM EDT - 2 years ago

Inhibikase Therapeutics Announces a 1-for-6 Reverse Stock Split


BillyTheKid62
BillyTheKid62 Aug. 1 at 5:40 PM
$IKT This stock makes my hemmroids bleed faster !
0 · Reply
buffalochips62
buffalochips62 Jul. 31 at 3:10 PM
$IKT seems this is just gonna keep slowly bleeding back to 1. Ugh.
2 · Reply
MB11111
MB11111 Jul. 24 at 2:38 PM
$IKT Ikt is hiring. Clinical trial jobs… https://www.inhibikase.com/careers Careers :: Inhibikase Therapeutics, Inc. (IKT)
1 · Reply
buffalochips62
buffalochips62 Jul. 24 at 1:51 PM
$IKT is the feed to this ticker broken or is it just me? I don’t see any updates in 12 days.?
0 · Reply
Mjf04288
Mjf04288 Jul. 11 at 3:45 PM
$IKT Volume has dried up the past 2 days. Company needs to provide some updates
1 · Reply
buffalochips62
buffalochips62 Jul. 10 at 6:16 PM
$IKT is this dead money for a while or are catalysts coming up in the next couple quarters? Thanks
2 · Reply
Finanz
Finanz Jul. 5 at 8:03 PM
$IKT Time for a short squeeze?
0 · Reply
TJC1791
TJC1791 Jun. 30 at 10:20 PM
$IKT https://www.ainvest.com/news/inhibikase-therapeutics-russell-2500-inclusion-strategic-pivot-small-cap-biotech-investors-parkinson-pipeline-shifts-2507/
1 · Reply
TJC1791
TJC1791 Jun. 28 at 4:31 PM
$IKT @PharmToBank how you feeling about this recent imatinib trial that seems to be well tolerated? Any concerns on the viability of IKT pro?
1 · Reply
Mjf04288
Mjf04288 Jun. 28 at 2:05 AM
$IKT What is going on? After hours volume 7.06 million
1 · Reply
stockanalysis_
stockanalysis_ Jun. 27 at 9:48 PM
After Hours Losers: $SERA $ODYS $AMIX $INTG $IKT View the entire list here: https://stockanalysis.com/markets/afterhours/?ref=saveontrading
0 · Reply
WillisMcGillis
WillisMcGillis Jun. 26 at 8:06 PM
$IKT Phase 3 Risvo https://www.globenewswire.com/news-release/2025/05/21/3085719/0/en/ABLi-Therapeutics-Announces-Details-of-the-End-of-Phase-2-Meeting-with-FDA-for-Evaluation-of-Risvodetinib-as-a-Treatment-for-Parkinson-s-Disease.html
2 · Reply
Major_Bagholder
Major_Bagholder Jun. 21 at 6:08 PM
$IKT How does the share price not immediately drop below a $1 with this filing?
2 · Reply
DonCorleone77
DonCorleone77 Jun. 21 at 1:42 PM
$IKT Inhibikase Therapeutics files $300M mixed securities shelf
1 · Reply
Mjf04288
Mjf04288 Jun. 20 at 10:17 PM
$IKT S-3 filed after close
0 · Reply
BiotechJedi1728
BiotechJedi1728 Jun. 18 at 11:55 AM
$IKT Why did that feel like an attempt at a flush out yesterday before an announcement is made? I just hate the greedy fvcks here… Just make your money. Stop messing with the SP. 🤦🏻‍♂️ You know what. F. That. I am buying this morning.
1 · Reply
Major_Bagholder
Major_Bagholder Jun. 17 at 3:21 PM
$IKT Some news would be nice.
0 · Reply
Finanz
Finanz Jun. 17 at 2:27 AM
$IKT The shorts seem to be in control and not ready to cover
0 · Reply
BillyTheKid62
BillyTheKid62 Jun. 14 at 7:41 PM
$IKT Owning this stock is like having a bad case of hemmroids . I know because i have both !
1 · Reply
little_jackie
little_jackie Jun. 13 at 10:42 PM
$LYEL You guys really need to run out @BiotechJedi1728 He pumps like mad. Ask him about $IKT
0 · Reply
little_jackie
little_jackie Jun. 13 at 10:41 PM
$DARE You guys haven't ran out @BiotechJedi1728 yet? This guy is so full of it. Ask him about his pumping of $IKT
0 · Reply
TJC1791
TJC1791 Jun. 11 at 8:23 PM
$IKT Check out this job at Inhibikase Therapeutics, Inc.: https://www.linkedin.com/jobs/view/4248093871
2 · Reply